v.231201
Showing details for project SYSMHC00010
| SampleID | NumReplicates | Organism | TissueType | CellType | MHCAllele |
|---|---|---|---|---|---|
| SampleID | NumReplicates | Organism | TissueType | CellType | MHCAllele |
| SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_PF1_Subject_04 | 1 | Human | HLA-A02:01,HLA-A01:01,HLA-B07:02,HLA-B44:03,HLA-C07:02,HLA-C16:01 | ||
| SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_RT_Subject_10 | 1 | Human | HLA-A02:01,HLA-A01:01,HLA-B18:01,HLA-B39:24,HLA-C05:01,HLA-C07:01 | ||
| SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_01 | 3 | Human | HLA-A03:01,HLA-A29:02,HLA-B08:01,HLA-B44:03,HLA-C07:01,HLA-C16:01 | ||
| SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_02 | 3 | Human | HLA-A03:01,HLA-A29:02,HLA-B08:01,HLA-B44:03,HLA-C07:01,HLA-C16:01 | ||
| SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_03 | 15 | Human | HLA-A02:01,HLA-A29:02,HLA-B57:01,HLA-B44:03,HLA-C07:01,HLA-C16:01 | ||
| SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_04 | 19 | Human | HLA-A02:01,HLA-A01:01,HLA-B07:02,HLA-B44:03,HLA-C07:02,HLA-C16:01 | ||
| SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_05 | 7 | Human | HLA-A03:01,HLA-A11:01,HLA-B44:03,HLA-B50:01 | ||
| SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_06 | 6 | Human | HLA-A02:01,HLA-A11:01,HLA-B40:01,HLA-B44:03,HLA-C03:01,HLA-C16:01 | ||
| SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_07 | 9 | Human | HLA-A02:01,HLA-A23:01,HLA-B18:01,HLA-B44:03,HLA-C04:01,HLA-C07:01 | ||
| SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_08 | 20 | Human | HLA-A02:01,HLA-A03:01,HLA-B07:02,HLA-C07:02 | ||
| SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_09 | 20 | Human | HLA-A02:01,HLA-A03:01,HLA-B07:02,HLA-C07:02 | ||
| SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_10 | 19 | Human | HLA-A02:01,HLA-A01:01,HLA-B18:01,HLA-B39:24,HLA-C05:01,HLA-C07:01 | ||
| SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_11 | 20 | Human | HLA-A02:01,HLA-A24:02,HLA-B15:01,HLA-B73:01,HLA-C03:03,HLA-C15:05 | ||
| SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_12 | 3 | Human | HLA-A02:01,HLA-B13:02,HLA-B41:01,HLA-C06:02,HLA-C17:01 | ||
| SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_13 | 3 | Human | HLA-A02:01,HLA-A11:01,HLA-B27:05,HLA-B56:01,HLA-C01:02,HLA-C02:02 | ||
| SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_14 | 4 | Human | HLA-A03:01,HLA-A32:01,HLA-B27:05,HLA-B45:01,HLA-C01:02,HLA-C16:01 | ||
| SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_15 | 9 | Human | HLA-A01:01,HLA-A32:01,HLA-B08:01,HLA-C07:01 | ||
| SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_16 | 3 | Human | HLA-A11:01,HLA-B14:02,HLA-B44:02,HLA-C05:01,HLA-C08:01 | ||
| SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_17 | 3 | Human | HLA-A11:01,HLA-B18:03,HLA-B35:01,HLA-C04:01,HLA-C07:01 | ||
| SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_18 | 3 | Human | HLA-A03:01,HLA-A24:02,HLA-B07:02,HLA-B27:05 | ||
| SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_pat_CELG_Subject_11 | 3 | Human | HLA-A02:01,HLA-A24:02,HLA-B15:01,HLA-B73:01,HLA-C03:03,HLA-C15:05 | ||
| SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_pat_C_Subject_08 | 3 | Human | HLA-A02:01,HLA-A03:01,HLA-B07:02,HLA-C07:02 | ||
| SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_pat_J_Subject_09 | 6 | Human | HLA-A02:01,HLA-A03:01,HLA-B07:02,HLA-C07:02 | ||
| SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_pat_MA_Subject_03 | 3 | Human | HLA-A02:01,HLA-A29:02,HLA-B57:01,HLA-B44:03,HLA-C07:01,HLA-C16:01 | ||
| SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_pat_PF1_Subject_04 | 3 | Human | HLA-A02:01,HLA-A01:01,HLA-B07:02,HLA-B44:03,HLA-C07:02,HLA-C16:01 | ||
| SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_pat_RT_Subject_10 | 3 | Human | HLA-A02:01,HLA-A01:01,HLA-B18:01,HLA-B39:24,HLA-C05:01,HLA-C07:01 |
Detailed view of sample SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_04
| ID | SampleID | RawFileName | Organism | Process | Tissue Type | Cell Type | Culture Conditions | Disease State | Comments | MHCClass | MHCAllele | PubMed ID | Peptide | Isolation Method | Antibody | Mass Spectrometer | LC System | iRT Peptides | Acquisition Mode | Fragmentation Method | Gradient | Gradient Length | Flow Rate | Replicate Number |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ID | SampleID | RawFileName | Organism | Process | Tissue_Type | Cell_Type | Culture_Conditions | Disease_State | Comments | MHCClass | MHCAllele | PubMed_ID | Peptide | Isolation_Method | Antibody | Mass_Spectrometer | LC_System | iRT_Peptides | Acquisition_Mode | Fragmentation_Method | Gradient | Gradient_Length | Flow_Rate | Replicate_Number |
| SYSMHC00010 | SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_04 | SYSMHC00010_PF1_rep3_021213_Fx100mM.raw | Human | In vitro | Blood | Lymphoblast cell | suspension | EBV transformed | class I | HLA-A02:01,HLA-A01:01,HLA-B07:02,HLA-B44:03,HLA-C07:02,HLA-C16:01 | 26857467 | native | Mild acid elution | Orbitrap Elite | no | DDA | CID | 5-40% | 56 | 1 | ||||
| SYSMHC00010 | SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_04 | SYSMHC00010_PF1_rep3_021213_Fx50mM.raw | Human | In vitro | Blood | Lymphoblast cell | suspension | EBV transformed | class I | HLA-A02:01,HLA-A01:01,HLA-B07:02,HLA-B44:03,HLA-C07:02,HLA-C16:01 | 26857467 | native | Mild acid elution | Orbitrap Elite | no | DDA | CID | 5-40% | 56 | 2 | ||||
| SYSMHC00010 | SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_04 | SYSMHC00010_PF1_rep3_021213_Fx600mM.raw | Human | In vitro | Blood | Lymphoblast cell | suspension | EBV transformed | class I | HLA-A02:01,HLA-A01:01,HLA-B07:02,HLA-B44:03,HLA-C07:02,HLA-C16:01 | 26857467 | native | Mild acid elution | Orbitrap Elite | no | DDA | CID | 5-40% | 56 | 3 | ||||
| SYSMHC00010 | SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_04 | SYSMHC00010_PF1_rep3_021213_Fx75mM.raw | Human | In vitro | Blood | Lymphoblast cell | suspension | EBV transformed | class I | HLA-A02:01,HLA-A01:01,HLA-B07:02,HLA-B44:03,HLA-C07:02,HLA-C16:01 | 26857467 | native | Mild acid elution | Orbitrap Elite | no | DDA | CID | 5-40% | 56 | 4 | ||||
| SYSMHC00010 | SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_04 | SYSMHC00010_PF1_rep4_021213_Fx100mM.raw | Human | In vitro | Blood | Lymphoblast cell | suspension | EBV transformed | class I | HLA-A02:01,HLA-A01:01,HLA-B07:02,HLA-B44:03,HLA-C07:02,HLA-C16:01 | 26857467 | native | Mild acid elution | Orbitrap Elite | no | DDA | CID | 5-40% | 56 | 5 | ||||
| SYSMHC00010 | SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_04 | SYSMHC00010_PF1_rep4_021213_Fx300mM.raw | Human | In vitro | Blood | Lymphoblast cell | suspension | EBV transformed | class I | HLA-A02:01,HLA-A01:01,HLA-B07:02,HLA-B44:03,HLA-C07:02,HLA-C16:01 | 26857467 | native | Mild acid elution | Orbitrap Elite | no | DDA | CID | 5-40% | 56 | 6 | ||||
| SYSMHC00010 | SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_04 | SYSMHC00010_PF1_rep4_021213_Fx50mM.raw | Human | In vitro | Blood | Lymphoblast cell | suspension | EBV transformed | class I | HLA-A02:01,HLA-A01:01,HLA-B07:02,HLA-B44:03,HLA-C07:02,HLA-C16:01 | 26857467 | native | Mild acid elution | Orbitrap Elite | no | DDA | CID | 5-40% | 56 | 7 | ||||
| SYSMHC00010 | SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_04 | SYSMHC00010_PF1_rep4_021213_Fx600mM.raw | Human | In vitro | Blood | Lymphoblast cell | suspension | EBV transformed | class I | HLA-A02:01,HLA-A01:01,HLA-B07:02,HLA-B44:03,HLA-C07:02,HLA-C16:01 | 26857467 | native | Mild acid elution | Orbitrap Elite | no | DDA | CID | 5-40% | 56 | 8 | ||||
| SYSMHC00010 | SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_04 | SYSMHC00010_PF1_rep4_021213_Fx75mM.raw | Human | In vitro | Blood | Lymphoblast cell | suspension | EBV transformed | class I | HLA-A02:01,HLA-A01:01,HLA-B07:02,HLA-B44:03,HLA-C07:02,HLA-C16:01 | 26857467 | native | Mild acid elution | Orbitrap Elite | no | DDA | CID | 5-40% | 56 | 9 | ||||
| SYSMHC00010 | SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_04 | SYSMHC00010_PF1_rep5_021213_Fx100mM.raw | Human | In vitro | Blood | Lymphoblast cell | suspension | EBV transformed | class I | HLA-A02:01,HLA-A01:01,HLA-B07:02,HLA-B44:03,HLA-C07:02,HLA-C16:01 | 26857467 | native | Mild acid elution | Orbitrap Elite | no | DDA | CID | 5-40% | 56 | 10 | ||||
| SYSMHC00010 | SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_04 | SYSMHC00010_PF1_rep5_021213_Fx300mM.raw | Human | In vitro | Blood | Lymphoblast cell | suspension | EBV transformed | class I | HLA-A02:01,HLA-A01:01,HLA-B07:02,HLA-B44:03,HLA-C07:02,HLA-C16:01 | 26857467 | native | Mild acid elution | Orbitrap Elite | no | DDA | CID | 5-40% | 56 | 11 | ||||
| SYSMHC00010 | SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_04 | SYSMHC00010_PF1_rep5_021213_Fx50mM.raw | Human | In vitro | Blood | Lymphoblast cell | suspension | EBV transformed | class I | HLA-A02:01,HLA-A01:01,HLA-B07:02,HLA-B44:03,HLA-C07:02,HLA-C16:01 | 26857467 | native | Mild acid elution | Orbitrap Elite | no | DDA | CID | 5-40% | 56 | 12 | ||||
| SYSMHC00010 | SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_04 | SYSMHC00010_PF1_rep5_021213_Fx600mM.raw | Human | In vitro | Blood | Lymphoblast cell | suspension | EBV transformed | class I | HLA-A02:01,HLA-A01:01,HLA-B07:02,HLA-B44:03,HLA-C07:02,HLA-C16:01 | 26857467 | native | Mild acid elution | Orbitrap Elite | no | DDA | CID | 5-40% | 56 | 13 | ||||
| SYSMHC00010 | SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_04 | SYSMHC00010_PF1_rep5_021213_Fx75mM.raw | Human | In vitro | Blood | Lymphoblast cell | suspension | EBV transformed | class I | HLA-A02:01,HLA-A01:01,HLA-B07:02,HLA-B44:03,HLA-C07:02,HLA-C16:01 | 26857467 | native | Mild acid elution | Orbitrap Elite | no | DDA | CID | 5-40% | 56 | 14 | ||||
| SYSMHC00010 | SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_04 | SYSMHC00010_PF1_rep6_021213_Fx300mM.raw | Human | In vitro | Blood | Lymphoblast cell | suspension | EBV transformed | class I | HLA-A02:01,HLA-A01:01,HLA-B07:02,HLA-B44:03,HLA-C07:02,HLA-C16:01 | 26857467 | native | Mild acid elution | Orbitrap Elite | no | DDA | CID | 5-40% | 56 | 15 | ||||
| SYSMHC00010 | SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_04 | SYSMHC00010_PF1_rep6_021213_Fx50mM.raw | Human | In vitro | Blood | Lymphoblast cell | suspension | EBV transformed | class I | HLA-A02:01,HLA-A01:01,HLA-B07:02,HLA-B44:03,HLA-C07:02,HLA-C16:01 | 26857467 | native | Mild acid elution | Orbitrap Elite | no | DDA | CID | 5-40% | 56 | 16 | ||||
| SYSMHC00010 | SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_04 | SYSMHC00010_PF1_rep6_021213_Fx600mM.raw | Human | In vitro | Blood | Lymphoblast cell | suspension | EBV transformed | class I | HLA-A02:01,HLA-A01:01,HLA-B07:02,HLA-B44:03,HLA-C07:02,HLA-C16:01 | 26857467 | native | Mild acid elution | Orbitrap Elite | no | DDA | CID | 5-40% | 56 | 17 | ||||
| SYSMHC00010 | SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_04 | SYSMHC00010_PF1_rep6_021213_Fx75mM.raw | Human | In vitro | Blood | Lymphoblast cell | suspension | EBV transformed | class I | HLA-A02:01,HLA-A01:01,HLA-B07:02,HLA-B44:03,HLA-C07:02,HLA-C16:01 | 26857467 | native | Mild acid elution | Orbitrap Elite | no | DDA | CID | 5-40% | 56 | 18 | ||||
| SYSMHC00010 | SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_04 | SYSMHC00010_PF1_rep6_021213_Fx100mM.raw | Human | In vitro | Blood | Lymphoblast cell | suspension | EBV transformed | class I | HLA-A02:01,HLA-A01:01,HLA-B07:02,HLA-B44:03,HLA-C07:02,HLA-C16:01 | 26857467 | native | Mild acid elution | Orbitrap Elite | no | DDA | CID | 5-40% | 56 | 19 |